Results 31 to 40 of about 312,210 (374)
Recommendations for Screening and Diagnosis of Chagas Disease in the United States
Journal of Infectious Diseases, 2021 Background Chagas disease affects an estimated 326 000–347 000 people in the United States and is severely underdiagnosed. Lack of awareness and clarity regarding screening and diagnosis is a key barrier.
Colin J. Forsyth +14 more
semanticscholar +1 more source
Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile. [PDF]
, 2016 PurposeWe have established a prospective cohort of 1959 patients with chronic Chagas cardiomyopathy to evaluate if a clinical prediction rule based on ECG, brain natriuretic peptide (BNP) levels, and other biomarkers can be useful in clinical practice ...
Bierrenbach, Ana Luiza +10 more
core +3 more sources
Prognosis of chronic Chagas heart disease and other pending clinical challenges
Memórias do Instituto Oswaldo Cruz, 2022 In this chapter, the main prognostic markers of Chagas heart disease are addressed, with an emphasis on the most recent findings and questions, establishing the basis for a broad discussion of recommendations and new approaches to managing Chagas ...
R. M. Torres +13 more
semanticscholar +1 more source
Postgraduate Medical Journal, 2006 Abstract Chagas disease is the clinical condition triggered by infection with the protozoan Trypanosoma cruzi. The infection is transmitted by triatomine insects while blood feeding on a human host. Field studies predict that one third of an estimated 18 million T cruzi-infected humans in Latin America will die of Chagas disease.
A R L, Teixeira +4 more
openaire +2 more sources
Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy [PDF]
, 2017 Background: Chagas’ disease is an important cause of cardiomyopathy in Latin America. We aimed to compare clinical characteristics and outcomes in patients with heart failure (HF) with reduced ejection fraction caused by Chagas’ disease, with other ...
Claudio R. Gimpelewicz +17 more
core +3 more sources
Inmunodiagnóstico de la infección chagásica por ELlSA
Biomédica: revista del Instituto Nacional de Salud, 1999 La demostración del agente infeccioso es la regla de oro en las parasitosis, pero, esto no siempre es factible. Por ello, en la infección chagásica ce recurre a la detección de anticuerpos contra Trypanosoma cruzi siendo las pruebas serodiagnósticas de ...
Myriam C. López +8 more
doaj +1 more source
Novel cruzain inhibitors for the treatment of Chagas' disease. [PDF]
, 2012 The protozoan parasite Trypanosoma cruzi, the etiological agent of Chagas' disease, affects millions of individuals and continues to be an important global health concern.
Arkin, Michelle R +6 more
core +1 more source
Canine Trypanosoma cruzi infection in the Bolivian Chaco [PDF]
, 2018 A cross-sectional study on Trypanosoma cruzi was carried out in 2013 to evaluate the role of dogs as possible source of infection for humans in two rural communities of the highly endemic Bolivian Chaco (Bartolo, Chuquisaca Department, n = 57 dogs; and ...
Bartoloni, Alessandro +9 more
core +2 more sources
Chagas Disease: From Discovery to a Worldwide Health Problem
Frontiers in Public Health, 2019 Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma cruzi) and identified its ...
K. Lidani +6 more
semanticscholar +1 more source
Access to diagnosis and treatment of Chagas disease/infection in endemic and non-endemic countries in the XXI century. [PDF]
, 2007 In this article, Médicos Sin Fronteras (MSF) Spain faces the challenge of selecting, piecing together, and conveying in the clearest possible way, the main lessons learnt over the course of the last seven years in the world of medical care for Chagas ...
Albajar-Vinas, P +4 more
core +4 more sources